Daily Multivitamin Use Linked to Slower Biological Aging in Older Adults

The intersection of nutrition and longevity science has reached a new milestone with the release of data suggesting that a standard daily multivitamin can measurably slow the biological aging process. While chronological age is an unchangeable metric of time, biological age reflects the functional state of an individual’s cells and tissues. This study, which tracked a large cohort of older adults, utilized advanced epigenetic clocks to determine that those taking a daily supplement exhibited a biological age significantly younger than their non-supplementing peers. This development marks a shift in the perception of multivitamins from simple nutritional insurance to potential tools for systemic longevity.

At the core of this discovery is the measurement of DNA methylation—chemical modifications to DNA that change as we age. By analyzing these biomarkers, researchers were able to quantify the rate of aging at a molecular level. The results indicate that the consistent presence of essential vitamins and minerals may prevent the 'epigenetic drift' typically seen in the elderly. This is particularly relevant given the high prevalence of subclinical micronutrient deficiencies in the aging population, which can accelerate cellular senescence and inflammation. The study suggests that correcting these gaps does more than just prevent deficiency; it actively preserves the integrity of the biological clock.

“

This study, which tracked a large cohort of older adults, utilized advanced epigenetic clocks to determine that those taking a daily supplement exhibited a biological age significantly younger than their non-supplementing peers.

This new data provides a critical third pillar to the findings from the Cocoa Supplement and Multivitamin Outcomes Study (COSMOS). Previous iterations of the COSMOS trial, led by researchers at Brigham and Women’s Hospital and Harvard Medical School, had already demonstrated that daily multivitamins could improve memory and slow cognitive aging by the equivalent of three years. By connecting these cognitive benefits to systemic biological aging markers, the medical community now has a more holistic view of how micronutrients influence the aging trajectory across the entire body, not just the brain.

From a market perspective, these findings provide a significant tailwind for the consumer health sector, particularly for major players like Haleon, the manufacturer of Centrum. For years, the supplement industry has faced skepticism regarding the efficacy of multivitamins for generally healthy individuals. However, the emergence of high-quality, large-scale clinical data is beginning to silence critics. As the 'longevity economy' continues to expand, consumers are increasingly seeking evidence-based interventions to extend their healthspan. This study positions the humble multivitamin as a low-cost, high-accessibility entry point into the burgeoning field of geroprotection, potentially disrupting more expensive and unproven longevity treatments.